NovoCure Q4 Sales $99.2M Beat $95.65M Estimate

NovoCure (NASDAQ:NVCR) reported quarterly sales of $99.2 million which beat the analyst consensus estimate of $95.65 million by 3.71 percent. This is a 42.38 percent increase over sales of $69.674 million the same

Benzinga · 01/13/2020 11:14

NovoCure (NASDAQ:NVCR) reported quarterly sales of $99.2 million which beat the analyst consensus estimate of $95.65 million by 3.71 percent. This is a 42.38 percent increase over sales of $69.674 million the same period last year.